These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 35033108)

  • 1. Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.
    Pi J; Zhang Z; Yang E; Chen L; Zeng L; Chen Y; Wang R; Huang D; Fan S; Lin W; Shen H; Xu JF; Zeng G; Shen L
    J Nanobiotechnology; 2022 Jan; 20(1):36. PubMed ID: 35033108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates.
    Shen L; Frencher J; Huang D; Wang W; Yang E; Chen CY; Zhang Z; Wang R; Qaqish A; Larsen MH; Shen H; Porcelli SA; Jacobs WR; Chen ZW
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6371-6378. PubMed ID: 30850538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
    BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques.
    Hoft SG; Kauffman KD; Sakai S; Lindestam Arlehamn CS; Sette A; Hoft DF; Herbert R; Barber DL
    mBio; 2023 Apr; 14(2):e0022023. PubMed ID: 36880755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.
    Rahman S; Magalhaes I; Rahman J; Ahmed RK; Sizemore DR; Scanga CA; Weichold F; Verreck F; Kondova I; Sadoff J; Thorstensson R; Spångberg M; Svensson M; Andersson J; Maeurer M; Brighenti S
    Mol Med; 2012 May; 18(1):647-58. PubMed ID: 22396020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of tuberculosis in macaques after intravenous BCG immunization.
    Darrah PA; Zeppa JJ; Maiello P; Hackney JA; Wadsworth MH; Hughes TK; Pokkali S; Swanson PA; Grant NL; Rodgers MA; Kamath M; Causgrove CM; Laddy DJ; Bonavia A; Casimiro D; Lin PL; Klein E; White AG; Scanga CA; Shalek AK; Roederer M; Flynn JL; Seder RA
    Nature; 2020 Jan; 577(7788):95-102. PubMed ID: 31894150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infection.
    Chancellor A; White A; Tocheva AS; Fenn JR; Dennis M; Tezera L; Singhania A; Elliott T; Tebruegge M; Elkington P; Gadola S; Sharpe S; Mansour S
    Tuberculosis (Edinb); 2017 Jul; 105():86-95. PubMed ID: 28610792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques.
    Sarfas C; White AD; Sibley L; Morrison AL; Gullick J; Lawrence S; Dennis MJ; Marsh PD; Fletcher HA; Sharpe SA
    Front Immunol; 2021; 12():754589. PubMed ID: 34707617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
    Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
    Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
    Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccination.
    Shen H; Wang Y; Chen CY; Frencher J; Huang D; Yang E; Ryan-Payseur B; Chen ZW
    Eur J Immunol; 2015 Feb; 45(2):442-51. PubMed ID: 25141829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.
    Du G; Chen CY; Shen Y; Qiu L; Huang D; Wang R; Chen ZW
    J Immunol; 2010 Oct; 185(7):3940-7. PubMed ID: 20805423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
    Hansen SG; Zak DE; Xu G; Ford JC; Marshall EE; Malouli D; Gilbride RM; Hughes CM; Ventura AB; Ainslie E; Randall KT; Selseth AN; Rundstrom P; Herlache L; Lewis MS; Park H; Planer SL; Turner JM; Fischer M; Armstrong C; Zweig RC; Valvo J; Braun JM; Shankar S; Lu L; Sylwester AW; Legasse AW; Messerle M; Jarvis MA; Amon LM; Aderem A; Alter G; Laddy DJ; Stone M; Bonavia A; Evans TG; Axthelm MK; Früh K; Edlefsen PT; Picker LJ
    Nat Med; 2018 Feb; 24(2):130-143. PubMed ID: 29334373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Intradermal Bacillus Calmette-Guérin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques.
    Tsujimura Y; Shiogama Y; Soma S; Okamura T; Takano J; Urano E; Murakata Y; Kawano A; Yamakawa N; Asaka MN; Matsuo K; Yasutomi Y
    J Immunol; 2020 Dec; 205(11):3023-3036. PubMed ID: 33097574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.